Ajanta Pharma is setting up new formulations plant in Dahej SEZ and Savli in Vadodara district of Gujarat with an investment of Rs.4000 million. The company will start work by Feb 2013 and will complete the same by 2014-15. Besides this, the company operates 4 manufacturing unit across India and one in Marutius. Ajanta is currently present in therapeutic areas of anti- malarial, cardiology, dermatology, gastroenterology, musculoskeletal, ophthalmology and respiratory.
Panacea Biotec had commissioned a new manufacturing facility at Baddi in Himachal Pradesh with an investment of Rs. 550 million. It will manufacture anti cancer formulations and will have a capacity of 1.2 million vials. It will cater to export markets of USA, where there is a rising demand for oncology products. Currently, the company caters to the market from its Navi Mumbai plant.
Lupin Pharmaceuticals is setting up a new formulation manufacturing facility in Multi modal International Cargo Hub and Airport (MHIAN) SEZ in Nagpur. The project cost is estimated at Rs. 4000 million and will produce new formulations for export to US, Japan and Europe. The project will go operational in 2013.
|
|
|
|
|
|
| 11,950 ₹ | 4950 ₹ | 4950 ₹ | 4950 ₹ | 3950 ₹ |
Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202 Mobile : 0-97898-37940 email : [email protected] Privacy Policy
